[Clinical use of natural kallikrein-protease inhibitors].
D000818:Animals; D007611:Aprotinin / Q000172:deficiency / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy; D001424:Bacterial Infections / Q000188:drug therapy; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D002056:Burns / Q000188:drug therapy; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006801:Humans; D007251:Influenza, Human / Q000188:drug therapy; D007610:Kallikreins / Q000037:antagonists & inhibitors*; D009203:Myocardial Infarction / Q000188:drug therapy; D009205:Myocarditis / Q000188:drug therapy; D010195:Pancreatitis / Q000188:drug therapy; D010455:Peptides / Q000172:deficiency / Q000627:therapeutic use; D011023:Pneumonia, Staphylococcal / Q000188:drug therapy; D012769:Shock / Q000188:drug therapy; D014020:Tissue Extracts / Q000172:deficiency / Q000627:therapeutic use; D014361:Trypsin Inhibitors / Q000172:deficiency / Q000627:therapeutic use; D019896:alpha 1-Antitrypsin Deficiency
D010455:Peptides; D014020:Tissue Extracts; D014361:Trypsin Inhibitors; C011475:gordox; C003041:pantripin; C014613:ingitril; D007611:Aprotinin; D007610:Kallikreins
Primenenie estestvennykh kallikrein-proteaznykh ingibitorov v klinike.